Search
Search Results
-
Autoimmune diseases and atherosclerotic cardiovascular disease
Autoimmune diseases are associated with a dramatically increased risk of atherosclerotic cardiovascular disease and its clinical manifestations. The...
-
Trained immunity in atherosclerotic cardiovascular disease
Trained immunity, also known as innate immune memory, is a persistent hyper-responsive functional state of innate immune cells. Accumulating evidence...
-
Uncovering atherosclerotic cardiovascular disease by PET imaging
Assessing atherosclerosis severity is essential for precise patient stratification. Specifically, there is a need to identify patients with residual...
-
Specialized pro-resolving mediators in vascular inflammation and atherosclerotic cardiovascular disease
Timely resolution of the acute inflammatory response (or inflammation resolution) is an active, highly coordinated process that is essential to...
-
Trajectories of atherosclerotic cardiovascular disease risk scores as a predictor for incident chronic kidney disease
BackgroundThe relationship between atherosclerosis and renal function is well established. Atherosclerotic cardiovascular disease (ASCVD) risk scores...
-
Noninvasive Atherosclerotic Phenoty**: The Next Frontier into Understanding the Pathobiology of Coronary Artery Disease
Purpose of ReviewDespite recent advances, coronary artery disease remains one of the leading causes of mortality worldwide. Noninvasive imaging...
-
Liver and atherosclerotic risks of patients with cryptogenic steatotic liver disease
Background and aimsIn 2023, a new nomenclature of “metabolic associated steatotic liver disease” (MASLD) has emerged by incorporating...
-
Low dose rivaroxaban for the management of atherosclerotic cardiovascular disease
Atherosclerotic cardiovascular disease is characterized by some risk of major adverse events despite the availability of effective medical therapies...
-
Shared inflammatory pathways of rheumatoid arthritis and atherosclerotic cardiovascular disease
The association between chronic inflammation and increased risk of cardiovascular disease in rheumatoid arthritis (RA) is well established. In the...
-
Comparative Analysis of Atherogenic Lipoproteins L5 and Lp(a) in Atherosclerotic Cardiovascular Disease
Purpose of ReviewLow-density lipoprotein (LDL) poses a risk for atherosclerotic cardiovascular disease (ASCVD). As LDL comprises various subtypes...
-
Surgical Management of Intracranial Atherosclerotic Disease
Purpose of the reviewIntracranial atherosclerotic disease is a complex stroke etiology with numerous challenges in its management. We present an...
-
Improving outcomes in atherosclerotic renovascular disease: importance of clinical presentation and multi-disciplinary review
Background and objectivesAtherosclerotic renal artery stenosis may cause hypertension, chronic kidney disease and heart failure, but large randomized...
-
Atherosclerotic Cardiovascular Disease Primary and Secondary Prevention in Latino Subgroups
BackgroundStudies assessing equity in the prevention of atherosclerotic cardiovascular disease (ASCVD) for Latinos living in the USA collectively...
-
Inflammatory risk and clinical outcomes according to polyvascular atherosclerotic disease status in patients undergoing PCI
BackgroundIndividuals suffering from polyvascular atherosclerotic disease (PolyVD) face a higher likelihood of adverse cardiovascular events....
-
Circulating trimethylamine N-oxide is correlated with high coronary artery atherosclerotic burden in individuals with newly diagnosed coronary heart disease
BackgroundTrimethylamine N-oxide (TMAO) is a metabolite derived from the gut microbiota and has been reported to be correlated with cardiovascular...
-
Epidemiology of multimorbidity associated with atherosclerotic cardiovascular disease in the United States, 1999–2018
BackgroundThe multimorbidity of Atherosclerotic cardiovascular disease (ASCVD) and many other chronic conditions is becoming common. This study aimed...
-
Plaque characteristics after endovascular treatment in patients with intracranial atherosclerotic disease
BackgroundEndovascular treatment (EVT) is an alternative option for symptomatic intracranial atherosclerotic disease (ICAD). However, the effect of...
-
A massive pulmonary arteriovenous fistula complicated with coronary atherosclerotic heart disease treated by interventional therapy: a case report
BackgroundPulmonary arteriovenous fistula (PAVF) is a rare disease, and its symptoms lack specificity. For patients with coronary heart disease(CHD),...
-
Risk factors for and risk of all-cause and atherosclerotic cardiovascular disease mortality in people with type 2 diabetes and peripheral artery disease: an observational, register-based cohort study
BackgroundType 2 diabetes (T2D) and peripheral artery disease (PAD) are recognized as independent risk factors contributing to excess mortality....
-
Implementing Reporting Standards for Polygenic Risk Scores for Atherosclerotic Cardiovascular Disease
Purpose of ReviewThere is considerable interest in using polygenic risk scores (PRSs) for assessing risk of atherosclerotic cardiovascular disease...
